• SNS-032 (BMS-387032): Precision Targeting of CDK Networks in

  2026-07-01

  Explore the multifaceted utility of SNS-032 (BMS-387032), a potent CDK2/7/9 inhibitor, in dissecting cell cycle and transcriptional control, with a focus on advanced cancer models and host-pathogen interactions. Uncover how this compound enables new depth in chronic lymphocytic leukemia research and beyond.

• ABT-263 (Navitoclax): Applied Workflows for Senescence & Apo

  2026-06-30

  ABT-263 (Navitoclax) empowers oncology and senescence researchers with precision control over apoptosis pathways, unlocking advanced cancer biology workflows. This article details experimental protocols, troubleshooting, and the latest innovations in selective senolysis and Bcl-2 inhibition.

• Novel 6C Medium Extends Mouse Corneal Epithelial Cell Prolif

  2026-06-30

  This study introduces a serum-free, small-molecule-based 6C medium that significantly prolongs the proliferative activity of mouse corneal epithelial cells (mCECs) in vitro and in vivo. By optimizing cell expansion and maintaining progenitor characteristics, the paradigm addresses a key bottleneck in corneal regenerative research and transplantation workflows.

• MCL-1’s Anti-Apoptotic Function Underpins Breast Cancer Surv

  2026-06-29

  The referenced study demonstrates that breast cancer cell survival critically depends on the canonical anti-apoptotic function of MCL-1, not its non-apoptotic roles. These findings provide a mechanistic rationale for targeting MCL-1 with selective inhibitors in cancer research and therapy.

• Reelin Signaling is Essential for Ketamine’s Antidepressant

  2026-06-29

  This study demonstrates that synaptic Reelin signaling is a critical prerequisite for ketamine-induced synaptic and behavioral antidepressant responses. Disruption of Reelin or its downstream effectors abolishes ketamine’s efficacy, providing mechanistic insight into the variable response rates seen in treatment-resistant depression.

• Chlorambucil in Translational Oncology: Mechanistic Insights

  2026-06-28

  This article explores how mechanistic understanding of chlorambucil, a nitrogen mustard alkylating agent, empowers translational researchers to design robust, insightful experiments. By integrating the latest systems biology perspectives, in vitro assay optimization, and strategic guidance for workflow reproducibility, the discussion highlights chlorambucil’s relevance for chronic lymphocytic leukemia treatment and advanced cancer models. Critical findings from recent dissertations and comparative literature are synthesized, and actionable protocol recommendations are provided.

• E-64d: Advancing Cysteine Protease Inhibition in Cell Death

  2026-06-27

  E-64d empowers researchers to dissect calpain and cathepsin-mediated cell death, including apoptosis and the recently characterized lysoptosis, with remarkable selectivity and cell permeability. Its robust performance in both in vitro and in vivo models makes it an indispensable tool for mechanistic studies in neuroprotection, cancer, and platelet biology.

• HyperScribe All in One mRNA Synthesis Kit: Advancing Immunoa

  2026-06-26

  Discover how the HyperScribe All in One mRNA Synthesis Kit enables high-fidelity ARCA capped mRNA synthesis for translational research and next-gen vaccine design. This in-depth analysis explores unique mechanistic insights and practical assay advantages not covered in prior guides.

• ABT-263 (Navitoclax): Applied Workflows for Apoptosis Assays

  2026-06-26

  ABT-263 (Navitoclax) empowers researchers to dissect Bcl-2 family-regulated apoptosis and senescence escape in cancer biology with exceptional selectivity and versatility. This guide translates cutting-edge melanoma research and validated workflows into actionable protocols and troubleshooting strategies, uniquely highlighting APExBIO as a trusted supplier for translational oncology studies.

• WM-8014: Applied Workflows for KAT6A Inhibitor-Driven Senesc

  2026-06-25

  WM-8014 offers precise, non-cytotoxic modulation of epigenetic states, enabling robust oncogene-induced senescence and cell cycle arrest assays. This guide details optimized protocols, troubleshooting insights, and advanced use-cases that unlock the full potential of this selective KAT6A inhibitor for cancer biology research.

• RNA Pol II Inhibition Drives Apoptosis Beyond Transcription

  2026-06-25

  Harper et al. demonstrate that cell death following RNA polymerase II inhibition is not a passive consequence of halted transcription, but an actively signaled apoptotic response triggered by loss of hypophosphorylated RNA Pol IIA. This finding reframes fundamental concepts in cell death mechanisms and suggests new directions for targeting apoptosis in cancer research.

• Aryl Hydrocarbon Receptor Mediates MEHP Toxicity in Mouse Ov

  2026-06-24

  This study demonstrates that the aryl hydrocarbon receptor (AhR) mediates the disruptive effects of mono(2-ethylhexyl) phthalate (MEHP) on mouse ovarian follicle growth and steroid hormone production. Pharmacological antagonism of AhR using CH 223191 partially rescues these adverse effects, highlighting a mechanistic link between environmental phthalates and reproductive toxicity.

• hiPSC-Derived Intestinal Organoids: A Model for CYP2C19 Subs

  2026-06-23

  This study introduces a streamlined 3D protocol to generate human induced pluripotent stem cell (hiPSC)-derived intestinal organoids with mature drug-metabolizing enterocytes. The model enables robust in vitro pharmacokinetic studies of CYP2C19 substrates, addressing limitations of traditional cell lines and animal models.

• Recombinant Annexin V: Advancing Apoptosis Detection Methods

  2026-06-23

  Brumatti et al. present a robust protocol for expressing and purifying recombinant annexin V, enabling sensitive, reproducible detection of apoptotic membrane changes. Their method underpins reliable flow cytometry and fluorescence microscopy analysis, streamlining cellular research workflows with high-yield and solubility of the probe.

• Pazopanib (GW-786034): Advanced Strategies for Precision Ang

  2026-06-22

  Discover how Pazopanib (GW-786034) empowers advanced cancer research through precision angiogenesis inhibition. Explore breakthrough insights on ATRX-deficient gliomas, practical protocol guidance, and nuanced scientific applications in tumor biology.

454 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page